Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07464470) titled 'Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers' on March 6.
Study Type: Observational
Primary Sponsor: Blokhin's Russian Cancer Research Center
Condition:
Gastric Cancer
Esophageal Cancer
Brain Metastases
Intervention:
Diagnostic Test: HER2 Testing
Diagnostic Test: MSI Testing
Diagnostic Test: PD-L1 Testing
Recruitment Status: Recruiting
Date of First Enrollment: April 1, 2026
Target Sample Size: 30
Countries of Recruitment:
Russia
To know more, visit https://clinicaltrials.gov/study/NCT07464470
Published by HT Digital Content Services w...